Role of Imiquimod in Skin Cancer Treatment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Dermatology,General Medicine
Reference44 articles.
1. Nonmelanoma skin cancer
2. Risk of Developing a Subsequent Nonmelanoma Skin Cancer in Patients With a History of Nonmelanoma Skin Cancer
3. Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
4. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential
5. Topical immunomodulators—progress towards treating inflammation, infection, and cancer
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer;International Journal of Molecular Sciences;2023-06-29
2. mRNA COVID 19 vaccine‐induced recall dermatitis after topical imiquimod;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-04-17
3. Parapsoriasis—A Diagnosis with an Identity Crisis: A Narrative Review;Dermatology and Therapy;2022-04-15
4. Arbor cutis resulting from using topical imiquimod for treating actinic keratosis and squamous cell carcinoma in situ;TURKDERM;2021-12-20
5. Pharmacological Approaches in Neurofibromatosis Type 1-Associated Nervous System Tumors;Cancers;2021-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3